Amado Rafael
Insider CIK 1662119 · ADAP President, R&D · PSTX Director · ZLAB See Remarks · ALLO EVP of R&D and CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab Ltd | S Sale | 2026-04-06 | 2026-04-08 | 2,739 | $20.45 | $56.0K | 57,022 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2026-04-02 | 2026-04-03 | 5,391 | — | $0 | 5,391 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2026-04-02 | 2026-04-03 | 5,391 | — | $0 | 69,671 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2026-04-02 | 2026-04-03 | 9,910 | $20.39 | $202.1K | 59,761 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2026-04-01 | 2026-04-03 | 19,523 | — | $0 | 39,046 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2026-04-01 | 2026-04-03 | 19,523 | — | $0 | 64,280 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2026-03-13 | 2026-03-16 | 2,957 | $18.63 | $55.1K | 44,757 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2026-03-12 | 2026-03-16 | 5,323 | — | $0 | 15,971 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2026-03-12 | 2026-03-16 | 5,323 | — | $0 | 47,714 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2026-03-04 | 2026-04-03 | 14,905 | — | $0 | 14,905 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2026-03-04 | 2026-03-16 | 33,783 | — | $0 | 33,783 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2026-03-04 | 2026-03-16 | 103,950 | — | $0 | 103,950 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2026-03-03 | 2026-03-05 | 10,000 | $17.38 | $173.8K | 42,391 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-12-31 | 2026-01-02 | 10,787 | $17.43 | $188.0K | 52,391 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2025-12-30 | 2026-01-02 | 21,000 | — | $0 | 42,000 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2025-12-30 | 2026-01-02 | 21,000 | — | $0 | 63,178 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-08-08 | 2025-08-12 | 3,000 | $35.00 | $105.0K | 42,178 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-04-04 | 2025-04-07 | 3,029 | $33.11 | $100.3K | 45,178 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2025-04-03 | 2025-04-07 | 5,391 | — | $0 | 10,782 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2025-04-03 | 2025-04-07 | 5,391 | — | $0 | 48,207 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-04-02 | 2025-04-03 | 7,541 | $35.89 | $270.6K | 42,816 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2025-04-01 | 2025-04-03 | 19,523 | — | $0 | 58,569 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2025-04-01 | 2025-04-03 | 19,523 | — | $0 | 50,357 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-03-17 | 2025-03-19 | 3,000 | $38.41 | $115.2K | 30,834 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2025-03-12 | 2025-03-14 | 65,523 | — | $0 | 65,523 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2025-03-12 | 2025-03-14 | 21,294 | — | $0 | 21,294 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 55,200 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 58,950 | — | $0 | 0 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-12-31 | 2025-01-02 | 7,583 | $26.28 | $199.3K | 33,834 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2024-12-30 | 2025-01-02 | 21,000 | — | $0 | 63,000 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2024-12-30 | 2025-01-02 | 21,000 | — | $0 | 41,417 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-08-12 | 2024-08-14 | 3,115 | $16.20 | $50.5K | 20,417 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-06-17 | 2024-06-18 | 19,650 | — | $0 | 58,950 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-04-04 | 2024-04-05 | 1,952 | $15.67 | $30.6K | 23,532 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2024-04-03 | 2024-04-05 | 5,391 | — | $0 | 16,173 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2024-04-03 | 2024-04-05 | 5,391 | $15.90 | $85.7K | 25,484 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2024-04-01 | 2024-04-03 | 78,092 | — | $0 | 78,092 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2024-04-01 | 2024-04-03 | 120,141 | — | $0 | 120,141 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-03-15 | 2024-03-19 | 2,544 | $18.86 | $48.0K | 20,093 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-01-02 | 2024-01-03 | 19,363 | $26.30 | $509.2K | 22,637 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2023-12-29 | 2024-01-03 | 21,000 | — | $0 | 0 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2023-12-29 | 2024-01-03 | 21,000 | — | $0 | 84,000 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2023-12-29 | 2024-01-03 | 21,000 | — | $0 | 42,000 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2023-12-29 | 2024-01-03 | 21,000 | — | $0 | 21,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-05-01 | 2023-05-02 | 55,200 | — | $0 | 55,200 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-05-01 | 2023-05-02 | 39,300 | — | $0 | 39,300 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2023-04-03 | 2023-04-05 | 21,564 | — | $0 | 21,564 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2023-04-03 | 2023-04-05 | 113,217 | — | $0 | 113,217 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2022-12-30 | 2023-01-03 | 183,700 | — | $0 | 183,700 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2022-12-30 | 2023-01-03 | 126,000 | — | $0 | 126,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2022-10-07 | 2022-10-11 | 8,464 | $11.83 | $100.1K | 541,946 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2022-10-07 | 2022-10-11 | 19,120 | — | $0 | 550,410 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2022-10-03 | 2022-10-05 | 8,968 | $11.06 | $99.2K | 531,290 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-08-02 | 2022-08-02 | 2,000 | $11.97 | $23.9K | 540,257 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-07-05 | 2022-07-06 | 2,000 | $11.44 | $22.9K | 542,257 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-06-21 | 2022-06-22 | 2,000 | $11.18 | $22.4K | 544,257 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-05-19 | 2022-05-19 | 11,500 | $7.40 | $85.1K | 546,257 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-03-23 | 2022-03-25 | 368,589 | — | $0 | 368,589 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2022-03-23 | 2022-03-25 | 237,358 | — | $0 | 557,477 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-03-15 | 2022-03-17 | 5,169 | $7.71 | $39.9K | 320,119 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-10-01 | 2021-10-04 | 11,507 | $24.35 | $280.2K | 323,928 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-05-18 | 2021-05-20 | 200,534 | — | $0 | 335,435 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-03-26 | 2021-03-30 | 92,365 | — | $0 | 92,365 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-03-26 | 2021-03-30 | 24,866 | — | $0 | 134,901 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-03-15 | 2021-03-17 | 2,798 | $38.05 | $106.5K | 110,035 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-07 | 2020-10-08 | 16,538 | $39.40 | $651.6K | 111,677 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-01 | 2020-10-02 | 9,752 | $36.37 | $354.7K | 128,215 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2020-03-18 | 2020-03-20 | 109,600 | — | $0 | 109,600 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2020-03-18 | 2020-03-20 | 30,800 | — | $0 | 135,962 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2019-09-03 | 2019-09-05 | 160,630 | — | $0 | 160,630 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2019-09-03 | 2019-09-05 | 105,162 | — | $0 | 105,162 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2019-08-06 | 2019-08-07 | 11,043 | $2.06 | $22.7K | 17,237 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2019-01-14 | 2019-01-16 | 3,028 | $5.37 | $16.3K | 4,974 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 1,006,224 | — | $0 | 1,006,224 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 224,724 | — | $0 | 224,724 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-08-06 | 2018-08-07 | 678,720 | — | $0 | 678,720 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 192,060 | — | $0 | 192,060 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 859,968 | — | $0 | 859,968 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-01-13 | 2017-01-18 | 2,072,976 | — | $0 | 2,072,976 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2016-01-18 | 2016-01-20 | 939,948 | — | $0 | 939,948 | SEC↗ |